Product nameAnti-GnRHR antibody
See all GnRHR primary antibodies
DescriptionGoat polyclonal to GnRHR
SpecificityThis antibody is expected to recognise both reported isoforms (NP_000397.1; NP_001012781.1).
Tested applicationsSuitable for: ELISA, WBmore details
Species reactivityReacts with: Human
Predicted to work with: Rabbit, Guinea pig, Dog, Pig
- Human Peripheral Blood Mononucleocyte lysate.
Storage instructionsShipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.
Storage bufferpH: 7.30
Preservative: 0.02% Sodium azide
Constituents: 0.5% Tris buffered saline, 0.5% BSA
Concentration information loading...
PurityImmunogen affinity purified
Immunizing Peptide (Blocking)
Our Abpromise guarantee covers the use of ab58561 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|WB||Use a concentration of 0.5 - 1.5 µg/ml. Detects a band of approximately 60 kDa (predicted molecular weight: 38 kDa).Can be blocked with Human GnRHR peptide (ab94807).
The observed molecular weight corresponds to earlier findings with products from other commercial sources.
- Information by UniProt
- GnRH receptor antibody
- GnRH-R antibody
- GNRHR antibody
Anti-GnRHR antibody (ab58561) at 0.5 µg/ml + Human Peripheral Blood Mononucleocyte lysate (35µg protein in RIPA buffer)
Predicted band size: 38 kDa
Observed band size: 60 kDa why is the actual band size different from the predicted?
Primary incubation was 1 hour. Detected by chemiluminescence.
This product has been referenced in:
- Dubovy SR et al. Expression of hypothalamic neurohormones and their receptors in the human eye. Oncotarget 8:66796-66814 (2017). Read more (PubMed: 28977997) »
- Seitz S et al. Triple negative breast cancers express receptors for LHRH and are potential therapeutic targets for cytotoxic LHRH-analogs, AEZS 108 and AEZS 125. BMC Cancer 14:847 (2014). ICC/IF ; Human . Read more (PubMed: 25410881) »